SCHEMBL8930679

SCHEMBL8930679

c1c2c(cc3c1OCO3)OCO2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.53
CYP3A4 P08684 3/20 0.52
ALDH1A1 P00352 3/20 0.46
HSD17B10 Q99714 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAPK1 P28482 1/20 0.44
TAAR1 Q96RJ0 1/20 0.42
ATM Q13315 1/20 0.42
CMA1 P23946 1/20 0.42
MAPT P10636 3/20 0.41
MEN1 O00255 2/20 0.41
POLB P06746 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
SLC6A4 P31645 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP1A2 P05177 1/20 0.41
MCL1 Q07820 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5768129 0.89 MAPT (0.47) ABCG2CYP3A4ALDH1A1HSD17B10TDP1
SCHEMBL1134704 0.85 CYP3A4 (0.48) ABCG2CYP3A4ALDH1A1HSD17B10TDP1
SCHEMBL18873211 0.82 CYP3A4 (0.41) ABCG2CYP3A4ALDH1A1HSD17B10TDP1
SCHEMBL1751672 0.79 AHR (0.53) ABCG2CYP3A4ALDH1A1HSD17B10TDP1
SCHEMBL2268770 0.79 CYP3A4 (0.56) ABCG2CYP3A4ALDH1A1MAPK1MAPT
SCHEMBL1742802 0.79 CYP3A4 (0.44) ABCG2CYP3A4ALDH1A1HSD17B10TDP1
SCHEMBL30787730 0.79 AHR (0.53) ABCG2CYP3A4ALDH1A1HSD17B10TDP1
SCHEMBL16472556 0.79 CYP3A4 (0.44) ABCG2CYP3A4ALDH1A1HSD17B10TDP1
SCHEMBL29415600 0.79 MAPT (0.56) ABCG2CYP3A4ALDH1A1HSD17B10TDP1
Water SCHEMBL28525395 0.77 MAPT (0.54) ABCG2CYP3A4ALDH1A1HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11524516-B2 Security ink system GLEITSMANN SECURITY INKS GMBH (DE) 2022-12-13 US claimed
EP-3774378-B1 SECURITY INK SYSTEM GLEITSMANN SECURITY INKS GMBH (DE) 2022-02-23 EP claimed
EP-3774378-A1 SECURITY INK SYSTEM Gleitsmann Security Inks GmbH (DE) 2021-02-17 EP claimed
US-20200316982-A1 SECURITY INK SYSTEM GLEITSMANN SECURITY INKS GMBH (DE) 2020-10-08 US claimed
WO-2020030413-A1 SECURITY INK SYSTEM GLEITSMANN SECURITY INKS GMBH (DE) 2020-02-13 WO claimed
EP-3608120-A1 SECURITY INK SYSTEM Gleitsmann Security Inks GmbH (DE) 2020-02-12 EP claimed
EP-4596562-A1 COMPOUND, METAL COMPLEX, CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION, CATALYST FOR OLEFIN POLYMERIZATION AND METHOD FOR PRODUCING OLEFIN POLYMER Mitsubishi Chemical Corporation (JP) 2025-08-06 EP disclosed
WO-2024071415-A1 COMPOUND, METAL COMPLEX, CATALYST COMPOSITION FOR OLEFIN POLYMERIZATION, CATALYST FOR OLEFIN POLYMERIZATION AND METHOD FOR PRODUCING OLEFIN POLYMER 日本ポリケム株式会社 2024-04-04 WO disclosed
US-11829036-B2 Optically anisotropic multilayer product and method for producing same ZEON CORPORATION (JP) 2023-11-28 US disclosed
US-11829036-B2 Optically anisotropic multilayer product and method for producing same ZEON CORPORATION (JP) 2023-11-28 US disclosed
EP-3668948-B1 POLYMERISABLE LIQUID CRYSTAL MATERIAL AND POLYMERISED LIQUID CRYSTAL FILM MERCK PATENT GMBH (DE) 2023-10-25 EP disclosed
EP-3668947-B1 POLYMERISABLE LC MEDIUM AND POLYMER FILM WITH FLAT OPTICAL DISPERSION MERCK PATENT GMBH (DE) 2023-09-27 EP disclosed
US-11524516-B2 Security ink system GLEITSMANN SECURITY INKS GMBH (DE) 2022-12-13 US disclosed
US-8268530-B2 Positive resist composition, method of forming resist pattern, polymeric compound, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2012-09-18 US disclosed
US-20100273106-A1 POSITIVE RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, POLYMERIC COMPOUND, AND COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2010-10-28 US disclosed
US-20100273106-A1 POSITIVE RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, POLYMERIC COMPOUND, AND COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2010-10-28 US disclosed
US-5599522-A CONTRAST ENHANCING AGENTS NYCOMED IMAGING AS (NO) 1997-02-04 US disclosed
EP-0515458-B1 TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI NYCOMED INNOVATION AB (SE) 1995-08-23 EP disclosed
EP-0515458-A1 TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI. HAFSLUND NYCOMED INNOVATION (SE) 1992-12-02 EP disclosed
WO-1991012024-A1 TRIARYLMETHYL RADICALS AND THE USE OF INERT CARBON FREE RADICALS IN MRI HAFSLUND NYCOMED INNOVATION AB (SE) 1991-08-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273106-A1 POSITIVE RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, POLYMERIC COMPOUND, AND COMPOUND RDX, DAD1, DDX1 ABCG2 478/4885CYP3A4 4136/4885ALDH1A1 1632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.